Latest1 information on COVID-19
Support teaching, research, and patient care.
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
Elizabeth Winters
+1 650-721-6509
All fields are required. *
We were not able to send your contact info at this time.